NCT03568422 2025-03-25
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Active not recruiting
Canadian Cancer Trials Group
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy Oncology Group
GOG Foundation